Quanterix Corporation
About Quanterix rporation
Quanterix Corporation is developing its proprietary Single Molecule Array (SiMoA(TM)) technology for the in vitro diagnostics and life science research markets.
Founded in 2007, the privately held company is based in Cambridge, Massachusetts, and is backed by leading life sciences investors, including ARCH Venture Partners, Bain Capital Ventures and Flagship Ventures.
Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.
- Industry : Diagnostics
Product portfolio of Quanterix rporation
News about Quanterix rporation
Here you will find Quanterix Corporation
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
